Medifast MED
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Medifast (MED) Core Market Data and Business Metrics
Latest Closing Price
$13.14Price-Earnings Ratio
69.16Total Outstanding Shares
10.94 Million SharesDividend
$1.65 Per Share QuarterlySIC Description
Miscellaneous Food Preparations & Kindred ProductsPrimary Exchange
New York Stock ExchangeHeadquarters
11445 Cronhill Drive, Owings Mills, MD, 21117
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 206,553 Shares | 6.25 | 3/14/2025 | 1,291,385 Shares |
| 303,205 Shares | 4.6 | 2/28/2025 | 1,394,907 Shares |
| 198,121 Shares | 6.78 | 2/14/2025 | 1,342,647 Shares |
| 208,287 Shares | 6.6 | 1/31/2025 | 1,374,004 Shares |
| 225,580 Shares | 6.23 | 1/15/2025 | 1,404,728 Shares |
| 260,444 Shares | 5.36 | 12/31/2024 | 1,394,880 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities | $24.48 Million |
| Net Cash Flow From Financing Activities, Continuing | $-1.51 Million |
| Net Cash Flow From Financing Activities | $-1.51 Million |
| Net Cash Flow From Investing Activities | $-26.52 Million |
| Net Cash Flow, Continuing | $-3.56 Million |
| Exchange Gains/Losses | $47,000 |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $598.68 Million |
| Net Income/Loss Attributable To Parent | $2.09 Million |
| Income Tax Expense/Benefit | $1.70 Million |
| Cost Of Revenue | $157.84 Million |
| Diluted Earnings Per Share | $0.19 |
| Selling, General, and Administrative Expenses | $441.75 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $2.02 Million |
| Other Comprehensive Income/Loss | $2.02 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-68,000 |
| Comprehensive Income/Loss | $2.02 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Inventory | $42.42 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Equity | $210.11 Million |
| Liabilities And Equity | $284.21 Million |
| Noncurrent Assets | $69.81 Million |
| Other Current Assets | $6.36 Million |
Historical Dividends
Current dividend: $1.65 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Sep 7, 2023 | Nov 7, 2023 | Sep 19, 2023 | $1.65 | Quarterly |
| Jun 15, 2023 | Aug 8, 2023 | Jun 27, 2023 | $1.65 | Quarterly |
| Mar 16, 2023 | May 9, 2023 | Mar 28, 2023 | $1.65 | Quarterly |
| Dec 8, 2022 | Feb 7, 2023 | Dec 20, 2022 | $1.64 | Quarterly |
| Sep 8, 2022 | Nov 8, 2022 | Sep 20, 2022 | $1.64 | Quarterly |
| Jun 16, 2022 | Aug 8, 2022 | Jun 28, 2022 | $1.64 | Quarterly |